Between 2004 and 2008, all-cause adult mortality declined more in PEPFAR focus countries relative to nonfocus countries. It was not possible to determine whether PEPFAR was associated with mortality effects separate from reductions in HIV-specific deaths.
No takes yet. Share an insight, caveat, or question.
Bendavid et al. (2012) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: